Transcript JP Morgan Conference

Life Technologies™ Proprietary | 1
AIPLA Winter Meeting Presentation
January 2013
L i f e Te c h n o l o g i e s To d a y
Life Technologies™ Proprietary | 2
1000s of products - Research & Applied Markets
Genetic Analysis
• Consumables and instruments used to sequence
and analyze DNA
• Consumables and instruments used to analyze
gene functions
• Next generation sequencing
Research Consumables
• Consumables for all types of sample preparation,
gene expression and cellular research
• Cell culture media for drug development
• Molecular and cell biology reagents
• Endpoint PCR benchtop instruments and consumables
Applied Sciences
•
•
•
•
•
BioProduction
Forensic Testing
Capillary Eletrophoresis and qPCR instruments
Animal Health and Food Safety
Medical Sciences
Life Technologies™ Proprietary | 3
Strong Competitive Advantages In All End Markets
Academic /
Government
• Broad product offerings
• Strong, most scientifically cited brands
Pharma /
Biotech
• Comprehensive solutions
• Customizable e-Procurement offerings
• World-renowned media formulation for biotech
Commercial
Applications
• Established protocols in Forensics
• Growing number of offerings for AgBio,
Food & Safety, Synthetic Genomics
Hospital /
Clinics
• Technology provider to diagnostic laboratories
Life Technologies™ Proprietary | 4
2. Lead product innovation
Offering a Full Range of Solutions for the Life Science
Market
Discovery
Next Generation
Sequencing
Confirmation / Validation
CE Sequencing
qPCR
Sample prep and
follow-on experiments
Best-in-class reagents and
consumables
Life Technologies™ Proprietary | 5
Building Our Diagnostics Franchise
•
•
Northern California based genomics testing provider
CLIA certified lab in all 50 states and physician/patient
software infrastructure
•
Launched Pervenio™ lung cancer test service in Q3
•
Positions LIFE as a partner of choice for drug and companion
diagnostic development
Life Technologies™ Proprietary | 6
Life Tech has a Large Patent Porfolio
•
Broad and deep patent portfolio
•
•
Over 4,000 owned or controlled patents
Relevant to molecular diagnostics
•
•
Underlying technologies
•
Sample prep
•
Genetic analysis
•
Methods, reagents and instruments
Specific molecular Dx assays [developing]
Life Tech’s portfolio relates to underlying molecular Dx technologies